LQR House to acquire NZ brokerage Fusion Five Continents for ~$126.9M; appoints two new directors

LQR House Inc.

Acquires 24% initially for $28.08M in USDT; remaining 76% for $98.8M in USDT, subject to regulatory approval.
Target is Fusion Five Continents Securities, a NZ brokerage enabling securities trading with stablecoin deposits.
Board appoints Yuting 'Tina' Luo and Hoi Ho George Wong as independent directors; $48k yearly cash fee each.
Initial closing by April 24, 2026; second closing after regulatory approvals; payment in Tether (USDT).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

LQR House Inc. entered into Share Purchase Agreement with Fusion Five Continents Securities Limited, a New Zealand limited company, and Dean Shields as the seller valued at $28,080,000 payable in Tether (USDT) for initial 24% (effective 2026-04-11).

Action: entry
Agreement: equity purchase
Counterparty: Fusion Five Continents Securities Limited, a New Zealand limited company, and Dean Shields as the seller
Value: $28,080,000 payable in Tether (USDT) for initial 24%
Effective: 2026-04-11

Exact text from the filing

On April 11, 2026, LQR House Inc. (the “ Company ”) entered into a Share Purchase Agreement (the “ Agreement ”) with Fusion Five Continents Securities Limited, a New Zealand limited company (the “ Target ”), and Dean Shields as the seller, pursuant to which the Company agreed to acquire all of the issued and outstanding shares of the Target in multiple closings.

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

LQR House Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-044043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.